SPS
MGNX icon

Susquehanna Portfolio Strategies’s MacroGenics MGNX Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$447K Buy
96,686
+78,304
+426% +$296K 0.01% 683
2026
Q1 		$53.1K Buy
+18,382
New +$39.2K ﹤0.01% 948
2024
Q2 		– Sell
-58,624
Closed -$863K – 657
2024
Q1 		$863K Sell
58,624
-90,560
-61% -$1.37M 0.02% 487
2023
Q4 		$1.44M Buy
+149,184
New +$1.03M 0.03% 510

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Susquehanna Portfolio Strategies's MGNX Position: Q2 2026 in Review

Susquehanna Portfolio Strategies increased its MacroGenics (MGNX) stake by 426% in Q2 2026, buying an estimated $296K and bringing the position to 96,686 shares worth $447K. The position accounts for 0.01% of the portfolio, ranked #683.

Susquehanna Portfolio Strategies first reported a position in MGNX in Q4 2023 and has held it in 4 quarters since. The position peaked at $1.44M in Q4 2023. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Susquehanna Portfolio Strategies held 96,686 shares of MacroGenics worth $447K as of Q2 2026.
  • Susquehanna Portfolio Strategies bought 78,304 MacroGenics shares in Q2 2026, an estimated $296K.
  • MacroGenics made up 0.01% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #683 holding.
  • Susquehanna Portfolio Strategies first reported a position in MacroGenics in Q4 2023 and has held it in 4 quarters since.
  • Susquehanna Portfolio Strategies's MacroGenics position peaked at $1.44M in Q4 2023.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.